Literature DB >> 12704115

Differences in gamma interferon production induced by listeriolysin O and ivanolysin O result in different levels of protective immunity in mice infected with Listeria monocytogenes and Listeria ivanovii.

Terumi Kimoto1, Ikuo Kawamura, Chikara Kohda, Takamasa Nomura, Kohsuke Tsuchiya, Yutaka Ito, Isao Watanabe, Taijin Kaku, Endang Setianingrum, Masao Mitsuyama.   

Abstract

Two pathogenic species in the genus Listeria, Listeria monocytogenes and Listeria ivanovii, are characterized by the production of hemolysins belonging to cholesterol-dependent cytolysins, listeriolysin O (LLO) and ivanolysin O (ILO), respectively. LLO, produced by L. monocytogenes, is able to induce gamma interferon (IFN-gamma) production and contributes to the generation of Th1-dependent protective immunity. On the other hand, nothing is known about the role of ILO, produced by L. ivanovii, in this regard. In this study, we immunized mice with 0.1 50% lethal dose (LD(50)) of L. monocytogenes and L. ivanovii. Protective immunity against a challenge with 10 LD(50) was generated in mice infected with L. monocytogenes, whereas L. ivanovii infection did not induce protection. After immunization, the level of IFN-gamma in serum samples was increased in mice given L. monocytogenes but not in those given L. ivanovii. To determine the IFN-gamma-inducing activity of cytolysins, recombinant protein was constructed. Recombinant ILO exhibited significantly lower IFN-gamma-inducing activity than LLO. By comparing the IFN-gamma-inducing activity of a chimera incorporating LLO and ILO, it was found that domains 1 to 3 of LLO were critical for IFN-gamma-inducing activity while the counterpart in ILO was unable to induce cytokine production. These results suggested that the weak ability of ILO to induce IFN-gamma production is responsible for the failure of L. ivanovii to generate effective protective immunity.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12704115      PMCID: PMC153848          DOI: 10.1128/IAI.71.5.2447-2454.2003

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  44 in total

Review 1.  The family of thiol-activated, cholesterol-binding cytolysins.

Authors:  M Palmer
Journal:  Toxicon       Date:  2001-11       Impact factor: 3.033

Review 2.  Listeria pathogenesis and molecular virulence determinants.

Authors:  J A Vázquez-Boland; M Kuhn; P Berche; T Chakraborty; G Domínguez-Bernal; W Goebel; B González-Zorn; J Wehland; J Kreft
Journal:  Clin Microbiol Rev       Date:  2001-07       Impact factor: 26.132

3.  Listeria ivanovii infection.

Authors:  M P Lessing; G D Curtis; I C Bowler
Journal:  J Infect       Date:  1994-09       Impact factor: 6.072

4.  Difference in cholesterol-binding and cytolytic activities between listeriolysin O and seeligeriolysin O: a possible role of alanine residue in tryptophan-rich undecapeptide.

Authors:  Y Ito; I Kawamura; C Kohda; H Baba; T Kimoto; I Watanabe; T Nomura; M Mitsuyama
Journal:  FEMS Microbiol Lett       Date:  2001-09-25       Impact factor: 2.742

5.  The virulence gene cluster of Listeria monocytogenes is also present in Listeria ivanovii, an animal pathogen, and Listeria seeligeri, a nonpathogenic species.

Authors:  E Gouin; J Mengaud; P Cossart
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

6.  The two distinct phospholipases C of Listeria monocytogenes have overlapping roles in escape from a vacuole and cell-to-cell spread.

Authors:  G A Smith; H Marquis; S Jones; N C Johnston; D A Portnoy; H Goldfine
Journal:  Infect Immun       Date:  1995-11       Impact factor: 3.441

7.  Listeria ivanovii infection in a patient with AIDS.

Authors:  A J Cummins; A K Fielding; J McLauchlin
Journal:  J Infect       Date:  1994-01       Impact factor: 6.072

8.  Dual roles of plcA in Listeria monocytogenes pathogenesis.

Authors:  A Camilli; L G Tilney; D A Portnoy
Journal:  Mol Microbiol       Date:  1993-04       Impact factor: 3.501

9.  Cytokine gene expression in mice at an early stage of infection with various strains of Listeria spp. differing in virulence.

Authors:  H Xiong; I Kawamura; T Nishibori; M Mitsuyama
Journal:  Infect Immun       Date:  1994-09       Impact factor: 3.441

10.  Correlation between the presence of virulence-associated genes as determined by PCR and actual virulence to mice in various strains of Listeria spp.

Authors:  T Nishibori; K Cooray; H Xiong; I Kawamura; M Fujita; M Mitsuyama
Journal:  Microbiol Immunol       Date:  1995       Impact factor: 1.955

View more
  10 in total

Review 1.  Role of pore-forming toxins in bacterial infectious diseases.

Authors:  Ferdinand C O Los; Tara M Randis; Raffi V Aroian; Adam J Ratner
Journal:  Microbiol Mol Biol Rev       Date:  2013-06       Impact factor: 11.056

2.  A defective Th1 response of the spleen in the initial phase may explain why splenectomy helps prevent a Listeria infection.

Authors:  N Kuranaga; M Kinoshita; T Kawabata; N Shinomiya; S Seki
Journal:  Clin Exp Immunol       Date:  2005-04       Impact factor: 4.330

Review 3.  Live, attenuated strains of Listeria and Salmonella as vaccine vectors in cancer treatment.

Authors:  Vafa Shahabi; Paulo C Maciag; Sandra Rivera; Anu Wallecha
Journal:  Bioeng Bugs       Date:  2010-01-04

4.  Multiple mechanisms contribute to the robust rapid gamma interferon response by CD8+ T cells during Listeria monocytogenes infection.

Authors:  Elsa N Bou Ghanem; Denise S McElroy; Sarah E F D'Orazio
Journal:  Infect Immun       Date:  2009-01-29       Impact factor: 3.441

5.  Cancer immunotherapy targeting the high molecular weight melanoma-associated antigen protein results in a broad antitumor response and reduction of pericytes in the tumor vasculature.

Authors:  Paulo Cesar Maciag; Matthew M Seavey; Zhen-Kun Pan; Soldano Ferrone; Yvonne Paterson
Journal:  Cancer Res       Date:  2008-10-01       Impact factor: 12.701

Review 6.  Listeria monocytogenes: a promising vehicle for neonatal vaccination.

Authors:  Zach Z Liang; Ashley M Sherrid; Anu Wallecha; Tobias R Kollmann
Journal:  Hum Vaccin Immunother       Date:  2014-02-10       Impact factor: 3.452

Review 7.  Listeriolysin O as a strong immunogenic molecule for the development of new anti-tumor vaccines.

Authors:  Rui Sun; Yuqin Liu
Journal:  Hum Vaccin Immunother       Date:  2013-02-11       Impact factor: 3.452

8.  Cytolysin-dependent escape of the bacterium from the phagosome is required but not sufficient for induction of the Th1 immune response against Listeria monocytogenes infection: distinct role of Listeriolysin O determined by cytolysin gene replacement.

Authors:  Hideki Hara; Ikuo Kawamura; Takamasa Nomura; Takanari Tominaga; Kohsuke Tsuchiya; Masao Mitsuyama
Journal:  Infect Immun       Date:  2007-05-21       Impact factor: 3.441

Review 9.  The MACPF/CDC family of pore-forming toxins.

Authors:  Carlos J Rosado; Stephanie Kondos; Tara E Bull; Michael J Kuiper; Ruby H P Law; Ashley M Buckle; Ilia Voskoboinik; Phillip I Bird; Joseph A Trapani; James C Whisstock; Michelle A Dunstone
Journal:  Cell Microbiol       Date:  2008-06-28       Impact factor: 3.715

10.  Listeria ivanovii Infection in Mice: Restricted to the Liver and Lung with Limited Replication in the Spleen.

Authors:  Mengying Zhou; Mingjuan Jiang; Chenyan Ren; Sijing Liu; Qikang Pu; Howard Goldfine; Hao Shen; Chuan Wang
Journal:  Front Microbiol       Date:  2016-06-07       Impact factor: 5.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.